StonvexLoading…
StonvexStonvexStonvexCore line items from IESC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $3.37B | $2.88B | $2.38B | $2.17B |
Operating Income | $383.53M | $300.88M | $159.78M | $56.01M |
Net Income | $305.98M | $219.12M | $108.29M | $34.76M |
EPS (Diluted) | $15.02 | $9.89 | $4.54 | $1.44 |
Total Assets | $1.60B | $1.24B | $981.60M | $934.71M |
Total Liabilities | $707.70M | $591.92M | $481.66M | $544.23M |
Cash & Equivalents | $127.17M | $100.83M | $75.77M | $24.85M |
Free Cash Flow OCF − CapEx | $218.84M | $189.25M | $136.24M | $-12.99M |
Shares Outstanding | 19.85M | 19.97M | 20.19M | 20.34M |